Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade

The pretreatment serum albumin/globulin ratio (AGR) has been used as a prognostic biomarker for various cancer types. However, the prognostic value of the AGR for prostate cancer, especially for metastatic prostate cancer (mPCa) after maximal androgen blockade (MAB), remains unclear. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning, Liu, Jian-Ye, Li, Xiong, Deng, Min-Hua, Long, Zhi, Tang, Jin, Yao, Kun, Zhang, Yi-Chuan, He, Le-Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337948/
https://www.ncbi.nlm.nih.gov/pubmed/30027930
http://dx.doi.org/10.4103/aja.aja_50_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337948/
https://www.ncbi.nlm.nih.gov/pubmed/30027930
http://dx.doi.org/10.4103/aja.aja_50_18

Ejemplares similares